Bill > HR2344

This bill, titled the "Prescription Drug Monitoring Act of 2021," aims to require the use of prescription drug monitoring programs (PDMPs) across the United States. The key provisions include: 1) Mandating that prescribing practitioners in covered states (those receiving funding under certain federal programs) must consult their state's PDMP before prescribing certain controlled substances and every 3 months thereafter; 2) Requiring PDMPs to provide proactive notifications to practitioners when patterns indicative of controlled substance misuse are detected; 3) Obligating dispensers to report each controlled substance prescription to the PDMP within 24 hours; 4) Requiring PDMPs to make de-identified data sets and annual reports available for public and private use; and 5) Empowering state agencies to analyze PDMP data and report any prescribers who fall outside of expected norms. The bill also allows the Attorney General or Secretary of Health and Human Services to withhold grant funding from states that fail to comply with these requirements.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/2344/all-info